A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?

Dermatol Ther. 2020 Jul;33(4):e13383. doi: 10.1111/dth.13383. Epub 2020 Apr 24.

Authors

Ömer Kutlu¹, Ahmet Metin¹

Affiliation

¹ Department of Dermatology and Venereology, School of Medicine, Uşak University, Uşak, Turkey.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antiviral Agents / administration & dosage
Antiviral Agents / adverse effects
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections / drug therapy*
Female
Humans
Hydroxychloroquine / administration & dosage*
Hydroxychloroquine / adverse effects
Oseltamivir / administration & dosage*
Oseltamivir / adverse effects
Pandemics
Pneumonia, Viral / drug therapy*
Psoriasis / etiology*
Psoriasis / pathology

Substances

Antiviral Agents
Oseltamivir
Hydroxychloroquine